November 26th 2024
Operating in an aging facility and/or utilizing outdated equipment may lead to drug shortages and high operating costs.
How to Evaluate the Cost Impact of Using Disposables in Biomanufacturing
June 1st 2008The current focus on cost-of-goods (COGS) models is underplaying the benefits of disposables technology in biopharmaceutical manufacturing. The best method for accounting for the benefits of reduced and delayed capital expenditures is through the use of NPV analysis.